Shopping Cart
Remove All
Your shopping cart is currently empty
Theralizumab (Synonyms: TGN1412, TABO8, TAB-08)
Catalog No. T77093 Copy Product Info
🥰Excellent
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Theralizumab
Copy Product Info🥰Excellent
Catalog No. T77093
Synonyms TGN1412, TABO8, TAB-08
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Theralizumab
Cas No. 906068-56-2
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $745 | In Stock | In Stock | |
| 5 mg | $1,980 | In Stock | In Stock | |
| 10 mg | $3,330 | - | In Stock | |
| 25 mg | $4,970 | - | In Stock | |
| 50 mg | $6,680 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:99.46% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis. |
| Synonyms | TGN1412, TABO8, TAB-08 |
| Reactivity | Human |
| Verified Activity | Immobilized Human CD28 Protein (His) (TMPJ-00103) at 1 μg/mL (100 μL/well) can bind Theralizumab. The EC50 is 43.82 ng/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD28 |
| Molecular Weight | 145.62 kDa |
| Cas No. | 906068-56-2 |
| Isotype | Human IgG4 kappa |
| Recommended Isotype Control |
| Storage | -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
Preview
Related Tags: buy Theralizumab | purchase Theralizumab | Theralizumab cost | order Theralizumab | Theralizumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.